Virtual Reality Digital Therapeutics for Seasonal Affective Disorder

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnglia Ruskin University

About this trial

Seasonal Affective Disorder (SAD) is commonly treated with bright light therapy. Virtual reality (VR) is an immersive computer-generated environment, which has been used to treat mental health difficulties, such as depression, social anxiety and stress. This study aims to compare the use of VR with bright light therapy in treating SAD.

Participants will be randomly allocated to either the VR condition or the light box condition and instructed to use the respective device every day for 14 days.

Eligibility criteria

Qualifiers

fluent in English and capable of giving informed consent

18 or older

resident in the United Kingdom and

able to access internet and attend Anglia Ruskin University's Cambridge campus

Disqualifiers

declared suffering from epilepsy (due to the risk that seizures may be triggered by VR use).

currently using photosensitizing medications or have significant retinal pathology, due to potentially detrimental effects of light box use. For other ophthalmologic conditions, consultation with an ophthalmologist will be recommended.

currently receiving active treatment for SAD, including antidepressant medication (less than 3 months), bright light treatment, or psychotherapy (e.g. CBT for seasonal affective disorder).

Trial design

Treatments tested in this trial

  • Virtual Reality (VR) Intervention
  • Light Box (LB) intervention

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Anglia Ruskin University

Lead sponsor

Reneural Technologies Ltd.

Collaborator

Aerial Icon Ltd.

Collaborator

Innovate UK, UKRI

Collaborator